PNKP Antibody

What are the primary applications for PNKP antibodies in research?

PNKP antibodies are primarily used in Western blotting (WB), immunohistochemistry (IHC), immunocytochemistry/immunofluorescence (ICC/IF), and immunoprecipitation (IP). These applications allow researchers to detect PNKP expression, localization, and interactions with other proteins. According to the search results, most commercially available antibodies are validated for WB and IHC applications, with recommended dilutions typically ranging from 1:500-1:2000 for WB and 1:50-1:500 for IHC, depending on the specific antibody .

How should I select the appropriate PNKP antibody for my experiment?

When selecting a PNKP antibody, consider:

• Target epitope location (N-terminal, C-terminal, or specific domain)

• Antibody type (monoclonal vs. polyclonal)

• Host species and potential cross-reactivity

• Validated applications and species reactivity

• Specific phosphorylation state detection (if studying PTMs)

For example, some antibodies specifically target the C-terminal region (like ab181107 ), while others target regions within amino acids 400-500 of human PNKP (like CAB21145 ). If studying phosphorylation at specific sites like T118, custom phospho-specific antibodies may be required .

What cell lines are typically used as positive controls for PNKP antibody validation?

According to the search results, several cell lines serve as reliable positive controls:

• Jurkat cells

• HeLa cells

• PC3 cells

• U2OS cells

• SK-BR-3 cells

• U-937 cells

Human testis tissue lysate is also frequently used as a positive control . For verification in mouse models, mouse spleen and rat testis tissues have been validated as positive samples .

How can I detect phosphorylated forms of PNKP in my experiments?

For detecting specific phosphorylated forms of PNKP:

• Use phospho-specific antibodies targeting the site of interest (e.g., pT118-PNKP or pS114-PNKP)

• Consider generating custom phospho-specific antibodies if commercial options aren't available

• Implement phosphatase inhibitors in your lysis buffer to preserve phosphorylation status

• Include appropriate controls (phosphatase-treated samples as negative controls)

Recent research has highlighted the importance of T118 phosphorylation by CDKs in PNKP recruitment to ssDNA gaps . Custom-generated antibodies against pT118-PNKP and pS114-PNKP have been used successfully at 1:1000 dilution in Western blotting .

What are the best approaches for studying PNKP's association with nascent DNA during replication?

To study PNKP's association with nascent DNA:

• iPOND (isolation of proteins on nascent DNA) technique: This method allows extraction and detection of proteins bound to nascent DNA. The protocol involves:

  • EdU incorporation (20 min)

  • Click chemistry to tag nascent DNA

  • Protein extraction and Western blotting

  • Detection with anti-PNKP antibody (1:1000 dilution)

This technique has successfully demonstrated that both WT-PNKP and T118-phosphorylated PNKP interact with nascent DNA, and that T118A mutation reduces this recruitment .

How can I analyze PNKP's role in DNA repair pathways using antibodies?

To investigate PNKP's function in DNA repair:

• DSB repair analysis: Monitor phosphorylation of histone H2AX and KAP1 after IR-induced DNA damage

• SSB repair activity assessment: Use BrdU incorporation assay with ExoIII digestion

• Replication-associated repair: S1 DNA fiber assay to detect ssDNA gap formation

• DNA damage response proteins: Co-immunoprecipitation with other repair factors (XRCC1, XRCC4)

For example, PNKP-/- cells show delayed reduction in phosphorylated H2AX and KAP1 after IR exposure, indicating defects in DSB repair .

What are the optimal conditions for PNKP immunoprecipitation?

For optimal PNKP immunoprecipitation:

Buffer composition:

• 50 mM Tris-HCl (pH 7.5)

• 150 mM NaCl

• 1% NP-40

• 5 mM EDTA

• 0.5% sodium deoxycholate

• 10% glycerol

• Protease inhibitor cocktail

• Phosphatase inhibitor cocktail

Protocol:

• Lyse cells in buffer (30 min on rotator at 4°C)

• Clear lysates by centrifugation (20,000×g, 20 min, 4°C)

• Incubate with GFP-Trap magnetic agarose beads (for GFP-tagged PNKP) or specific anti-PNKP antibody

• Incubate for 4 hours with mixing on rotator at 4°C

• Wash beads five times with lysis buffer

• Elute in 2× SDS sample buffer

This approach has been used successfully to study PNKP interactions with proteins like CDK1 or CDK2 .

What controls should be included when using PNKP antibodies in knockout/knockdown studies?

When using PNKP antibodies in knockout/knockdown studies, include:

• Positive controls: Wildtype cell lysates or tissues known to express PNKP

• Negative controls:

  • PNKP-/- cell lysates created via CRISPR/Cas9 (as described in search result )

  • siRNA knockdown samples with validated PNKP depletion

• Loading controls: GAPDH, β-actin, or other housekeeping proteins

• Antibody specificity controls: Peptide competition or overexpression systems

The search results describe PNKP-/- cell lines created using CRISPR/Cas9 with the sgRNA target sequences cloned into the pSpCas9n(BB)-2A-Puro (PX462) vector, which can serve as excellent negative controls .

What are the recommended protocols for immunofluorescence detection of PNKP?

For immunofluorescence detection of PNKP:

Fixation and permeabilization:

• Fix cells with 4% formaldehyde (15 min, 4°C)

• Permeabilize with PBS containing 0.2% Triton X-100 (5 min, 4°C)

• Block in PBS with 2% BSA (30 min)

Primary antibody reaction:

• Incubate with anti-PNKP antibody (1:500 dilution) in PBS-T with 1% BSA (2 hr, room temperature)

• Wash three times with PBS

Secondary antibody reaction:

• Incubate with fluorophore-conjugated secondary antibody (1:2000) in PBS-T with 1% BSA (1 hr, room temperature, in dark)

• Wash five times with PBS

• Mount with DAPI-containing medium

This approach allows visualization of PNKP localization, particularly in response to DNA damage or during different cell cycle phases .

How can PNKP antibodies be used to study cell cycle-dependent regulation?

To study cell cycle-dependent regulation of PNKP:

• Synchronize cells using methods appropriate for capturing specific cell cycle phases

• Analyze PNKP phosphorylation status using phospho-specific antibodies

• Co-stain with cell cycle markers:

  • Cyclin A2 (S phase)

  • Cyclin E1 (G1/S transition)

• Perform co-immunoprecipitation with cell cycle regulators like CDK1 and CDK2

Recent research has demonstrated that CDKs regulate phosphorylation of threonine 118 (T118) in PNKP, allowing recruitment to gapped DNA structures during DNA replication .

What methods are available for studying PNKP's role in clinical samples with neurological disorders?

For studying PNKP in clinical samples from patients with neurological disorders:

• Genetic screening for PNKP mutations (particularly in MCSZ, AOA4, and CMT2B2)

• Immunohistochemistry on brain tissue sections using anti-PNKP antibodies (1:50-1:500 dilution)

• Western blotting on patient-derived cells to assess PNKP expression levels

• Functional assays to determine DNA repair capacity

PNKP mutations are associated with microcephaly with early onset seizures (MCSZ), ataxia with oculomotor apraxia type 4 (AOA-4), and Charcot–Marie–Tooth disease (CMT2B2) . Most disease-causing mutations are found in the FHA, phosphatase, or kinase domains, not in the linker region containing T118 .

How can researchers evaluate the impact of PNKP mutations on progenitor cell populations?

To evaluate PNKP's role in progenitor cell populations:

• Generate conditional knockout models:

  • Use inducible Cre-loxP systems (e.g., 4-OHT administration in Pnkp^fl/fl mice)

  • Confirm PNKP deletion by Western blotting and immunostaining

• Analyze progenitor populations:

  • Hair follicle progenitors

  • Spermatogonial progenitors

  • Neural progenitor cells

• Assess DNA damage:

  • γH2AX staining as a marker of DNA damage

  • Cell death assays (TUNEL, cleaved caspase-3)

Research has shown that PNKP knockout in adult mice impairs the growth of various progenitor populations, with increased DNA damage and cell death observed in affected tissues .

What considerations are important when analyzing PNKP in cancer samples?

When analyzing PNKP in cancer samples:

• Compare expression levels between tumor and matched normal tissues

• Assess phosphorylation status of PNKP at sites like T118, S114, and S126

• Correlate with DNA repair capacity and genomic instability markers

• Consider PNKP inhibition as a potential therapeutic strategy

Studies have indicated that PNKP mutations may contribute to tumor initiation within susceptible cells in the CNS by limiting DNA damage repair . Additionally, inhibiting PNKP activity or T118 phosphorylation might represent potential targets for cancer therapy .

What are common issues with PNKP antibodies and how can they be resolved?

How should researchers validate novel PNKP phosphorylation sites?

For validating novel PNKP phosphorylation sites:

• Generate phospho-specific antibodies against the site of interest

• Create phospho-mimetic and phospho-dead mutants (e.g., T→E and T→A for threonine sites)

• Perform in vitro kinase assays to confirm the responsible kinase

• Use phosphatase treatments as negative controls

• Implement mass spectrometry for definitive identification

The study described in search result validated T118 phosphorylation by generating phospho-specific antibodies and creating PNKP T118A mutants, which showed reduced recruitment to DNA replication sites and impaired interaction with CDK1/2.